Clinical proteomics: From biological sample to clinical exploitation

Edwin Lasonder

doi:10.3390/proteomes5020010

Clinical proteomics: From biological sample to clinical exploitation

Edwin Lasonder^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

2 Citations (Scopus)

16 Downloads (Pure)

Abstract

Technological advances in mass spectrometry instrumentation and proteomics methodologies are moving the field of clinical proteomics towards the analysis of large numbers of patient samples in a reasonable time. The Special Issue ‘Clinical proteomics’ reviews the current proteomic work flow from biological sample preparation to clinical exploitation with samples collected from human body fluids, tissues or isolated cells, and highlights the trend towards integrated omics approaches for clinical usage.

Original language	English
Article number	10
Number of pages	3
Journal	Proteomes
Volume	5
Issue number	2
Early online date	6 Apr 2017
DOIs	https://doi.org/10.3390/proteomes5020010
Publication status	Published - 1 Jun 2017
Externally published	Yes

Access to Document

10.3390/proteomes5020010Licence: CC BY

proteomes-05-00010Final published version, 139 KBLicence: CC BY

Cite this

@article{dd85f58ee3484574b9dd728c162557af,

title = "Clinical proteomics: From biological sample to clinical exploitation",

abstract = "Technological advances in mass spectrometry instrumentation and proteomics methodologies are moving the field of clinical proteomics towards the analysis of large numbers of patient samples in a reasonable time. The Special Issue {\textquoteleft}Clinical proteomics{\textquoteright} reviews the current proteomic work flow from biological sample preparation to clinical exploitation with samples collected from human body fluids, tissues or isolated cells, and highlights the trend towards integrated omics approaches for clinical usage.",

author = "Edwin Lasonder",

year = "2017",

month = jun,

day = "1",

doi = "10.3390/proteomes5020010",

language = "English",

volume = "5",

journal = "Proteomes",

issn = "2227-7382",

publisher = "MDPI AG",

number = "2",

}

TY - JOUR

T1 - Clinical proteomics

T2 - From biological sample to clinical exploitation

AU - Lasonder, Edwin

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Technological advances in mass spectrometry instrumentation and proteomics methodologies are moving the field of clinical proteomics towards the analysis of large numbers of patient samples in a reasonable time. The Special Issue ‘Clinical proteomics’ reviews the current proteomic work flow from biological sample preparation to clinical exploitation with samples collected from human body fluids, tissues or isolated cells, and highlights the trend towards integrated omics approaches for clinical usage.

AB - Technological advances in mass spectrometry instrumentation and proteomics methodologies are moving the field of clinical proteomics towards the analysis of large numbers of patient samples in a reasonable time. The Special Issue ‘Clinical proteomics’ reviews the current proteomic work flow from biological sample preparation to clinical exploitation with samples collected from human body fluids, tissues or isolated cells, and highlights the trend towards integrated omics approaches for clinical usage.

UR - https://www.scopus.com/pages/publications/85032997132

UR - https://pearl.plymouth.ac.uk/handle/10026.1/8815

U2 - 10.3390/proteomes5020010

DO - 10.3390/proteomes5020010

M3 - Editorial

AN - SCOPUS:85032997132

SN - 2227-7382

VL - 5

JO - Proteomes

JF - Proteomes

IS - 2

M1 - 10

ER -

Clinical proteomics: From biological sample to clinical exploitation

Abstract

Access to Document

Other files and links

Fingerprint

Cite this